GeneReach Biotechnology Net Asset Quality Index
GeneReach Biotechnology net asset quality index. GeneReach Biotechnology (4171) has a Net Asset Quality Index of 67.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$858.12 Million minus total liabilities of NT$276.64 Million yields net assets of NT$581.48 Million. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of GeneReach Biotechnology for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of GeneReach Biotechnology (2017–2025)
Net asset quality index of GeneReach Biotechnology from 2017 to 2025. This chart shows how GeneReach Biotechnology's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the index stands at 67.8%, representing net assets of NT$581.48 Million against total assets of NT$858.12 Million TWD. Check asset allocation strategy of GeneReach Biotechnology to assess the company's strategic physical and investment asset allocation.
GeneReach Biotechnology Net Asset Quality Index by Year (2017–2025)
GeneReach Biotechnology net asset quality index by year from 2017 to 2025. The table below presents the year-by-year Net Asset Quality Index for GeneReach Biotechnology from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is GeneReach Biotechnology worth.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 67.7% | NT$596.72 Million | NT$881.05 Million | NT$284.34 Million | ▼ -0.3 pp |
| 2024 | 68.0% | NT$725.49 Million | NT$1.07 Billion | NT$341.00 Million | ▼ -5.3 pp |
| 2023 | 73.3% | NT$862.44 Million | NT$1.18 Billion | NT$313.71 Million | ▲ +5.3 pp |
| 2022 | 68.0% | NT$1.10 Billion | NT$1.62 Billion | NT$519.23 Million | ▲ +3.4 pp |
| 2021 | 64.6% | NT$1.09 Billion | NT$1.68 Billion | NT$596.35 Million | ▼ -4.5 pp |
| 2020 | 69.1% | NT$857.76 Million | NT$1.24 Billion | NT$382.75 Million | ▼ -8.8 pp |
| 2019 | 77.9% | NT$593.05 Million | NT$760.87 Million | NT$167.82 Million | ▲ +33.1 pp |
| 2018 | 44.8% | NT$311.15 Million | NT$693.83 Million | NT$382.68 Million | ▲ +3.3 pp |
| 2017 | 41.6% | NT$250.63 Million | NT$602.84 Million | NT$352.21 Million | — |